ACCELERATE
AT A GLANCE
- International strategies to develop cancer drugs for children
- Launched in 2016 by SIOPE and ITCC
- Incorporated as a not-for-profit organization in 2019
- Collaboration among academia, advocates, regulators, and biopharmaceutic companies
- +1000 experts from over 50 countries
- In collaboration with key drug regulatory authorities
- 9 Paediatric Strategy Forums resulting in 15 publications
- 10 Annual Conferences resulting in 7 Research Working Groups
- New Educational Program and international webinars
New Paragraph
WHAT WE DO
Paediatric Strategy Forums
Multi-stakeholder meetings in which strategies regarding new drug development are discussed. Each Forum focuses on either a given paediatric malignancy or the development of a class of compounds with regards to their mechanism of action.
Annual Conference
Speakers present and discuss clinical/preclinical pediatric oncology research, evolutions in the regulatory landscape worldwide, and other key challenges in the path toward accelerating the development of new and more innovative therapies for children and adolescents with cancer.
Research & Working Groups
ACCELERATE actively explores and researches into specific paediatric oncology challenges and propose solutions through its Working Groups.
Education
ACCELERATE is committed to building a broad knowledge base on how to advance new therapies for children and adolescents with cancer, and we believe that education is the key.
UPCOMING EVENTS AND INITIATIVES
Supported by
